FTO and cancer: Meanwhile, meclofenamic acid (MA), a nonsteroidal anti-inflammatory agent, was identified to specifically inhibit FTO by competitively binding to FTO sites of m6A-modified oncogenic mRNAs, thus effectively suppressing the cancer cell proliferation [185].